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Objective: We present prenatal diagnosis of pseudomosaicism for trisomy 5 and a review of the literature
of mosaic trisomy 5 at amniocentesis.
Case Report: A 39-year-old woman underwent amniocentesis at 17 weeks of gestation, which revealed a
karyotype of 47,XY,þ5[1]/46,XY[20]. The single colony with trisomy 5 had ﬁve metaphase cells, and all
ﬁve cells had the karyotype of 47,XY,þ5. Repeat amniocentesis performed at 20 weeks of gestation
revealed a karyotype of 46,XY in 27/27 colonies. Simultaneously, interphase ﬂuorescence in situ hy-
bridization (FISH), array comparative genomic hybridization (aCGH), and quantitative ﬂuorescent poly-
merase chain reaction (QF-PCR) were performed on uncultured amniocytes. Interphase FISH revealed no
trisomy 5 in 100 uncultured amniocytes. aCGH revealed no genomic imbalance. QF-PCR excluded uni-
parental disomy 5. A healthy 3662-g male baby was delivered with a normal karyotype in cord blood and
3.75% (3/80 cells) of trisomy 5 cells in uncultured urinary cells compared with 0.95% (1/105 cells) of
trisomy 5 cells in normal control examined by FISH at 1.5 months of age. A review of seven cases with
mosaic trisomy 5 at amniocentesis shows that 4/7 had clinically normal outcome, 3/7 had structural
defects, mainly the heart, 6/6 had normal karyotype in blood, and 2/3 had mosaic trisomy 5 in the fetal
tissues.
Conclusion: Prenatal diagnosis of mosaic trisomy 5 should alert the possibility of fetal structural ab-
normalities, especially the heart, and culture artifacts. We suggest that the application of molecular
cytogenetic techniques such as aCGH, interphase FISH, and QF-PCR on uncultured amniocytes is useful in
our understanding of the mosaic status at repeat amniocentesis.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
We previously reported the application of interphase ﬂuores-
cence in situ hybridization (FISH) on uncultured amniocytes ats and Gynecology, MacKay
Road, Taipei 10449, Taiwan.
).
bstetrics & Gynecology. Publishedrepeat amniocentesis for rapid diagnosis of truemosaicism in a case
of Level II mosaicism involving trisomy 21 in a single colony from an
in situ culture of amniocytes [1]. In this case report, we additionally
demonstrate the usefulness of performing interphase FISH and
array comparative genomic hybridization (aCGH) on uncultured
amniocytes at repeat amniocentesis for rapid diagnosis of pseudo-
mosaicism in a case of Level II mosaicism for trisomy 5 in a single
colony from an in situ culture of amniocytes at prenatal diagnosis.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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A 39-year-old, Gravid 3, Para 2, woman underwent amniocen-
tesis at 17 weeks of gestation because of advanced maternal age.
Cytogenetic analysis of cultured amniocytes revealed Level II
mosaicism for trisomy 5 and a karyotype of 47,XY,þ5[1]/46,XY[20].
Of the 21 colonies of cultured amniocytes, only one colony had the
karyotype of 47,XY,þ5, whereas the other 20 colonies had the
karyotype of 46,XY. The single colony with trisomy 5 had ﬁve
metaphase cells, and all these ﬁve cells had the karyotype of
47,XY,þ5. The father had a karyotype of 46,XYand themother had a
karyotype of 46,XX. Prenatal ultrasound ﬁndings were unremark-
able. At 20 weeks of gestation, the woman underwent repeat
amniocentesis. Interphase FISH and aCGH were performed on un-
cultured amniocytes, and conventional cytogenetic analysis was
performed on cultured amniocytes. Polymorphic DNA marker
analysis by quantitative ﬂuorescent polymerase chain reaction (QF-
PCR) was performed on the DNAs extracted from uncultured
amniocytes and parental blood samples. aCGH on uncultured
amniocytes using CytoScan 750K array (Affymetrix, Santa Clara, CA,
USA) showed no genomic imbalance. Interphase FISH on uncul-
tured amniocytes using a 5p15.33-speciﬁc probe (RP11-325I22,
dye: ﬂuorescein isothiocyanate, green,1,318,107e1,509,826) [hg 19]
and a 5p11-speciﬁc probe (RP11-489A19, dye: Texas Red, red,
46,155,848e46,356,409) [hg 19] showed two green signals and two
red signals in all 100 interphase cells examined. For the probe RP11-
325I22, the normal control case had a positive result of three sig-
nals in 1/105 cells, and for the probe RP11-489A19, the normal
control case had a positive result of three signals in 1/105 cells.
Cytogenetic analysis of cultured amniocytes at repeated amnio-
centesis revealed a karyotype of 46,XY in all of the 27 colonies. QF-
PCR using the informative marker of D5S592 (5q23.1) excluded
uniparental disomy 5. A healthy 3662-g male baby was delivered at
38 weeks of gestation. The cord blood had a karyotype of 46,XY in
40/40 of cultured lymphocytes. The neonate was normal at the age
of 1.5 months at postnatal follow-ups. Interphase FISH analysis of
uncultured urinary cells at 1.5 months of age revealed 3.75% (3/
80 cells) of trisomy 5 cells in uncultured urinary cells compared
with 0.95% (1/105 cells) of trisomy 5 cells in normal control using
this FISH probe.
Discussion
Mosaic trisomy 5 at amniocentesis is very rare. To date, at least
seven cases with mosaic trisomy 5 at amniocentesis had been re-
ported [2e8]. Richkind et al [2] ﬁrst reported prenatal detection of
mosaic trisomy 5 (78.9% in 38 colonies and 81.3% in 16 colonies,
respectively, in two samplings) by amniocentesis in a fetus with
normal outcome. The neonate was normal at 6 months of age. No
trisomy 5 was found in cord blood and foreskin. Penchaszadeh et al
[3] reported prenatal diagnosis of mosaic trisomy 5 (18/
45 cells ¼ 40%) by amniocentesis in a fetus. The blood karyotype
was normal. The neonate postnatally manifested low birth weight,
systolic murmur, and preauricular pit. Casamassima et al [4] re-
ported prenatal diagnosis of mosaic trisomy 5 (14/60 cells ¼ 23%)
by amniocentesis in a fetus with no mosaicism in the cord blood
sample and a clinically normal outcome. Sciorra et al [5] reported
prenatal diagnosis of mosaic trisomy 5 (6/24 cells ¼ 25%) by
amniocentesis in a fetus with no mosaicism in the cord blood at
cord blood sampling. The neonate postnatally manifested multiple
dysmorphic features and congenital anomalies includingeventration of the diaphragm and ventricular septal defect. Mosaic
trisomy 5 (8/40 cells ¼ 20%) was found in the skin ﬁbroblasts of the
neonate. The cord blood karyotype was 46,XY (106/106 cells). Hsu
et al [6] reported prenatal diagnosis of mosaic trisomy 5 (6.7% in
30 cells) by amniocentesis in a fetus. The neonate was normal after
birth. Villa et al [7] reported prenatal diagnosis of mosaic trisomy 5
(5/46 colonies ¼ 10.9%) by amniocentesis in a fetus with a normal
karyotype in the blood. The neonate had normal psychomotor
development but growth parameters less than the 3rd centile.
Brown et al [8] reported prenatal diagnosis of mosaic trisomy 5
(50% mosaicism) by amniocentesis in a fetus with congenital heart
defect, agenesis of the corpus callosum, and a cloverleaf skull.
Mosaic trisomy 5 was found in fetal tissues, except the blood tissue
which had a normal karyotype. A review of the literature shows
that among the seven reported cases of mosaic trisomy 5 detected
by amniocentesis, 4/7 had clinically normal outcome, and 3/7 had
structural defects, mainly ventricular septal defect; and 6/6 had
normal karyotype in the blood when blood cytogenetic analysis
was performed, and 2/3 had mosaic trisomy 5 in the fetal tissues
other than blood when tissue sampling was performed.
In summary, we presented a review of mosaic trisomy 5 at
amniocentesis. Prenatal diagnosis of mosaic trisomy 5 should alert
the possibility of fetal structural abnormalities, especially the heart,
and culture artifacts. We suggest that the application of molecular
cytogenetic techniques such as aCGH, interphase FISH, and QF-PCR
on uncultured amniocytes is useful in our understanding of the
mosaic status at repeat amniocentesis.Conﬂict of interest
The authors have no conﬂicts of interest relevant to this article.Acknowledgments
This work was supported by research grants MOST-103-2314-B-
195-010 and MOST-104-2314-B-195-009 from the Ministry of Sci-
ence and Technology and MMH-E-105-04 from Mackay Memorial
Hospital, Taipei, Taiwan.References
[1] Chen CP, Wang PT, Lin SP, Chern SR, Chen YT, Wu PS, et al. Interphase FISH on
uncultured amniocytes at repeat amniocentesis for rapid diagnosis of true
mosaicism in a case of level II mosaicism involving trisomy 21 in a single colony
from an in situ culture of amniocytes. Taiwan J Obstet Gynecol 2014;53:120e2.
[2] Richkind KE, Apostol RA, Puck SM. Prenatal detection of trisomy 5 mosaicism
with normal outcome. Prenat Diagn 1987;7:143.
[3] Penchaszadeh VB, Morejon DP, Gervis J, Schwartz M, Mahoney MJ, Babu A.
Prenatally detected trisomy 5 mosaicism in amniotic ﬂuid conﬁrmed in the
newborn. Am J Hum Genet 1988;43:A64 [Abstract].
[4] Casamassima AC, Wilmot PL, Mahoney MJ, Scott RV, Shapiro LR. Trisomy 5
mosaicism in amniotic ﬂuid with normal outcome. Clin Genet 1989;35:282e4.
[5] Sciorra LJ, Hux C, Day-Salvadore D, Lee ML, Mandelbaum DE, Brady-Yasbin S,
et al. Trisomy 5 mosaicism detected prenatally with an affected liveborn. Prenat
Diagn 1992;12:477e82.
[6] Hsu LY, Yu MT, Neu RL, Van Dyke DL, Benn PA, Bradshaw CL, et al. Rare trisomy
mosaicism diagnosed in amniocytes, involving an autosome other than chro-
mosomes 13, 18, 20, and 21: karyotype/phenotype correlations. Prenat Diagn
1997;17:201e42.
[7] Villa N, Redaelli S, Borroni C, Colombo C, Roncaglia N, Sala E, et al. Fetal trisomy
5 mosaicism: case report and literature review. Am J Med Genet A 2007;143A:
2343e6.
[8] Brown S, Higgins S, Hutchinson R, Bain S, Moore L, Haan E. A case of mosaicism
for trisomy of chromosome 5 detected at amniocentesis. Twin Res Hum Genet
2009;12:210.
